Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Immune and metabolic alterations in first episode psychosis (FEP) patients
To view or add a comment, sign in GLP-1 Treated Patients with Diabetes Have Raised Risk for Eye Condition People who start treatment with a GLP 1 receptor agonist for type 2 diabetes have slightly increased risk of developing ischemic optic neuropathy than those treated with other medications
on Progress and Achieve Your Milestones
They found widespread associations with benefits to cognitive and behavioral health, while also revealing increased risks for pancreatitis and kidney conditions, among others
US$ 23.99
US$ 23.67
US$ 24.21
US$ 29.53
US$ 29.87
